Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers transformational therapies for rare, severe, and debilitating neuromuscular diseases. Our approach is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity in neuromuscular disease, cardiometabolic disease, oncology, fibrosis, and anemia.